From Forbes:
Drug developer Pfizer Inc. said Friday it will appeal a Canadian federal court decision denying its application to block approval of a generic version of the cholesterol-lowering drug Lipitor.
Indian generic drug maker Ranbaxy Pharmaceuticals Inc. is asking for approval of its version of Lipitor. The ruling deals with a patent that Pfizer (nyse: PFE - news - people ) said holds market exclusivity until July 2010. ...more
Sunday, January 28, 2007
Pfizer to Appeal Canadian Decision
It will be interesting to see where this legal battle goes. I think we'll be hearing about this for most of 2007.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment